Novel therapies for multiple myeloma

Craig T Wallington-Beddoe, Stuart M Pitson, Craig T Wallington-Beddoe, Stuart M Pitson

No abstract available

Keywords: immunomodulatory agent; monoclonal antibody; myeloma; proteasome inhibitor; therapy.

References

    1. Kumar SK, et al. Leukemia. 2014;28:1122–28.
    1. Röllig C, et al. Lancet. 2015;385:2197–208.
    1. Obeng EA, et al. Blood. 2006;107:4907–16.
    1. Reeder CB, et al. Blood. 2010;115:3416–17.
    1. Dimopoulos MA, et al. Lancet Oncol. 2016;17:27–38.
    1. Bonnet A, Moreau P. Expert Opin Drug Saf. 2017;16:973–80.
    1. Holstein SA, McCarthy PL. Drugs. 2017;77:505–20.
    1. Zhang, et al. Oncotarget. 2017;8:34001–17.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever